Skip to Main Content
MLS - Evolving Treatments in Immunotherapy & Targeted Therapies - February 8, 2020 - San Francisco, CA

MLS - Evolving Treatments in Immunotherapy & Targeted Therapies - February 8, 2020 - San Francisco, CA

 

 

This Master Lecture Series (MLS) will provide current, practical information on the management of immunotherapy and targeted therapies. Novel agents and strategies will be discussed with the potential to shape the future of cancer therapy. Leading experts will address critical topics in personalized therapy, and the latest clinical data impacting the treatment of GI, GU (PAR Inhibitors), Melanoma, Lung (RET/MET/ VEGFR2) & breast cancer (HER2 PI3K/Akt). Cutting-edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to participate with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

This educational activity is designed to meet the educational needs of medical oncologists, nurses, advanced nurse practitioners, pharmacists, physician assistants, and other health professionals involved in the treatment of cancer. 

 

  • When

  • Saturday, February 8, 2020
    8:00 AM - 4:15 PM
    Atlantic Time

  • Where

  • 333 O'Farrell Street
    San Francisco, CA 94102
    USA

Conference Management

MECC image  

6619 South Dixie Highway #341
Miami, FL 33143
T: 305.663.1628 | F: 305.675.2718
www.meccinc.com 

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!
MSN MSN
Top